Clinical suspicion and parathyroid carcinoma management. 2006

Fabio Luiz de Menezes Montenegro, and Marcos Roberto Tavares, and Marcelo Doria Durazzo, and Claudio Roberto Cernea, and Anói Castro Cordeiro, and Alberto Rosseti Ferraz
Department of Head and Neck Surgery, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil. fabiomonte@uol.com.br

OBJECTIVE Adequate management of parathyroid carcinoma apparently relates to the surgeons ability to identify it at the first operation. The objective of this paper was to evaluate the role of clinical suspicion in the management of parathyroid carcinoma. METHODS Retrospective analysis of parathyroid carcinoma patients treated in Department of Head and Neck Surgery, Faculdade de Medicina da Universidade de São Paulo. METHODS Cross-sectional study of 143 patients who underwent surgery from 1995 to 2000, due to hyperparathyroidism. These cases were reviewed to ascertain whether preoperative and intraoperative suspicion of parathyroid carcinoma were helpful during the operation, and which factors demonstrated the suspicion of cancer best. RESULTS Among 66 patients with primary hyperparathyroidism there were four cases of parathyroid carcinoma (6.1%), and one case was found in secondary hyperparathyroidism (1.3%). Palpable nodules were found in five patients with primary hyperparathyroidism, four of them with parathyroid carcinoma. Preoperative levels of calcium in primary hyperparathyroidism with cancer patients varied from 12.0 mg/dl to 18.2 mg/dl. Two patients had gross macroscopic spread of the tumor to adjacent structures. Except for one patient, with extensive disease, tumors were resected en bloc. In secondary hyperparathyroidism, parathyroid carcinoma was found in a fifth mediastinal gland. One atypical adenoma was observed. CONCLUSIONS High levels of calcium, palpable tumors and adherence to close structures are more common in parathyroid carcinoma. These clinical signs may be helpful for decision-making during parathyroid surgery.

UI MeSH Term Description Entries
D006961 Hyperparathyroidism A condition of abnormally elevated output of PARATHYROID HORMONE (or PTH) triggering responses that increase blood CALCIUM. It is characterized by HYPERCALCEMIA and BONE RESORPTION, eventually leading to bone diseases. PRIMARY HYPERPARATHYROIDISM is caused by parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. SECONDARY HYPERPARATHYROIDISM is increased PTH secretion in response to HYPOCALCEMIA, usually caused by chronic KIDNEY DISEASES.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010282 Parathyroid Neoplasms Tumors or cancer of the PARATHYROID GLANDS. Cancer of Parathyroid,Parathyroid Cancer,Cancer of the Parathyroid,Neoplasms, Parathyroid,Parathyroid Adenoma,Parathyroid Carcinoma,Adenoma, Parathyroid,Adenomas, Parathyroid,Cancer, Parathyroid,Cancers, Parathyroid,Carcinoma, Parathyroid,Carcinomas, Parathyroid,Neoplasm, Parathyroid,Parathyroid Adenomas,Parathyroid Cancers,Parathyroid Carcinomas,Parathyroid Neoplasm
D002277 Carcinoma A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for "cancer." Carcinoma, Anaplastic,Carcinoma, Spindle-Cell,Carcinoma, Undifferentiated,Carcinomatosis,Epithelial Neoplasms, Malignant,Epithelioma,Epithelial Tumors, Malignant,Malignant Epithelial Neoplasms,Neoplasms, Malignant Epithelial,Anaplastic Carcinoma,Anaplastic Carcinomas,Carcinoma, Spindle Cell,Carcinomas,Carcinomatoses,Epithelial Neoplasm, Malignant,Epithelial Tumor, Malignant,Epitheliomas,Malignant Epithelial Neoplasm,Malignant Epithelial Tumor,Malignant Epithelial Tumors,Neoplasm, Malignant Epithelial,Spindle-Cell Carcinoma,Spindle-Cell Carcinomas,Tumor, Malignant Epithelial,Undifferentiated Carcinoma,Undifferentiated Carcinomas
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000236 Adenoma A benign epithelial tumor with a glandular organization. Adenoma, Basal Cell,Adenoma, Follicular,Adenoma, Microcystic,Adenoma, Monomorphic,Adenoma, Papillary,Adenoma, Trabecular,Adenomas,Adenomas, Basal Cell,Adenomas, Follicular,Adenomas, Microcystic,Adenomas, Monomorphic,Adenomas, Papillary,Adenomas, Trabecular,Basal Cell Adenoma,Basal Cell Adenomas,Follicular Adenoma,Follicular Adenomas,Microcystic Adenoma,Microcystic Adenomas,Monomorphic Adenoma,Monomorphic Adenomas,Papillary Adenoma,Papillary Adenomas,Trabecular Adenoma,Trabecular Adenomas
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Fabio Luiz de Menezes Montenegro, and Marcos Roberto Tavares, and Marcelo Doria Durazzo, and Claudio Roberto Cernea, and Anói Castro Cordeiro, and Alberto Rosseti Ferraz
January 2012, International journal of surgical oncology,
Fabio Luiz de Menezes Montenegro, and Marcos Roberto Tavares, and Marcelo Doria Durazzo, and Claudio Roberto Cernea, and Anói Castro Cordeiro, and Alberto Rosseti Ferraz
January 2009, American journal of otolaryngology,
Fabio Luiz de Menezes Montenegro, and Marcos Roberto Tavares, and Marcelo Doria Durazzo, and Claudio Roberto Cernea, and Anói Castro Cordeiro, and Alberto Rosseti Ferraz
April 2001, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,
Fabio Luiz de Menezes Montenegro, and Marcos Roberto Tavares, and Marcelo Doria Durazzo, and Claudio Roberto Cernea, and Anói Castro Cordeiro, and Alberto Rosseti Ferraz
November 1997, The American surgeon,
Fabio Luiz de Menezes Montenegro, and Marcos Roberto Tavares, and Marcelo Doria Durazzo, and Claudio Roberto Cernea, and Anói Castro Cordeiro, and Alberto Rosseti Ferraz
January 2023, Frontiers in endocrinology,
Fabio Luiz de Menezes Montenegro, and Marcos Roberto Tavares, and Marcelo Doria Durazzo, and Claudio Roberto Cernea, and Anói Castro Cordeiro, and Alberto Rosseti Ferraz
March 2004, Cancer,
Fabio Luiz de Menezes Montenegro, and Marcos Roberto Tavares, and Marcelo Doria Durazzo, and Claudio Roberto Cernea, and Anói Castro Cordeiro, and Alberto Rosseti Ferraz
April 2004, Current opinion in otolaryngology & head and neck surgery,
Fabio Luiz de Menezes Montenegro, and Marcos Roberto Tavares, and Marcelo Doria Durazzo, and Claudio Roberto Cernea, and Anói Castro Cordeiro, and Alberto Rosseti Ferraz
January 2002, Indian journal of cancer,
Fabio Luiz de Menezes Montenegro, and Marcos Roberto Tavares, and Marcelo Doria Durazzo, and Claudio Roberto Cernea, and Anói Castro Cordeiro, and Alberto Rosseti Ferraz
September 2017, Minerva endocrinologica,
Fabio Luiz de Menezes Montenegro, and Marcos Roberto Tavares, and Marcelo Doria Durazzo, and Claudio Roberto Cernea, and Anói Castro Cordeiro, and Alberto Rosseti Ferraz
January 2021, JCO oncology practice,
Copied contents to your clipboard!